Hyundai Pharmaceutical Co
Korea - SeoulPharmaceutical
Focus: Hyundai Pharmaceutical is a Korean small molecule and generic pharma company focused on respiratory, neurology, and nephrology indications. The company operates from Seoul with a modest pipeline of early-stage programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Hyundai Pharmaceutical Co
AI assessmentNot HiringNo open roles listed right now. Follow Hyundai Pharmaceutical Co to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Surfolase capsule
Healthy MaleClinical Trials (1)
NCT02395913Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)
Phase 1Help build intelligence for Hyundai Pharmaceutical Co
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.